Position in LLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$26,720,238
-$7,686,720 QoQ
Shares Held
29,051
-9.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 82.56170183470448.ToString("F0")%
Shared 0.ToString("F0")%
None 17.438298165295514.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds $409,752,047 across 2 Drug Manufacturers - General names. LLY ranks #2 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,942,155 | $383,031,809 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
29,051 | $26,720,238 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,720,238 | 29,051 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $34,406,958 | 32,016 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $11,731,125 | 15,375 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,032,593 | 20,567 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $37,844,848 | 45,822 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $35,014,060 | 45,355 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $24,063,902 | 27,162 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,759,153 | 1,943 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,540,360 | 1,980 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||